Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
PUT
Cboe Global Markets
CBOE
$32.1B
| $32M | 0.02% |
231,800
+12,100
| +6% | +$1.65M |
|
1027
Comfort Systems
FIX
$56.2B
| $31.9M | 0.02% |
194,440
+21,982
| +13% | +$3.27M |
|
1028
Viridian Therapeutics
VRDN
$2.76B
| $31.8M | 0.02% |
1,337,788
+723,699
| +118% | +$18.6M |
|
1029
Exelixis
EXEL
$13.9B
| $31.8M | 0.02% |
1,663,988
+1,506,354
| +956% | +$29M |
|
|
SRDX
1030
DELISTED
Surmodics
SRDX
| $31.8M | 0.02% |
1,015,248
+17,946
| +2% | +$410K |
|
1031
Monster Beverage
MNST
$95.2B
| $31.7M | 0.02% |
1,105,200
+583,864
| +112% | +$16.6M |
|
1032
TriNet
TNET
$3.18B
| $31.7M | 0.02% |
334,224
+193,555
| +138% | +$17.6M |
|
|
SKX
1033
DELISTED
Skechers
SKX
| $31.7M | 0.02% |
601,377
-152,450
| -20% | -$7.8M |
|
1034
EPR Properties
EPR
$4.64B
| $31.6M | 0.02% |
674,682
-267,978
| -28% | -$11.3M |
|
1035
PG&E
PCG
$40B
| $31.5M | 0.02% |
1,821,893
+282,412
| +18% | +$4.78M |
|
1036
Freshpet
FRPT
$3.59B
| $31.4M | 0.02% |
476,998
+333,161
| +232% | +$21.8M |
|
1037
CALL
Starbucks
SBUX
$121B
| $31.2M | 0.02% |
315,000
+197,800
| +169% | +$20.5M |
|
|
ARNC
1038
DELISTED
Arconic Corporation
ARNC
| $31.2M | 0.02% |
1,054,873
+459,566
| +77% | +$12.7M |
|
1039
Trimble
TRMB
$13.9B
| $31.2M | 0.02% |
588,772
+167,828
| +40% | +$8.21M |
|
1040
Trex
TREX
$4.81B
| $31.1M | 0.02% |
+474,244
| New | +$26.5M |
|
1041
CALL
Illumina
ILMN
$34B
| $31.1M | 0.02% |
170,340
+97,558
| +134% | +$19.7M |
|
|
TMHC
1042
DELISTED
Taylor Morrison
TMHC
| $31.1M | 0.02% |
636,973
+301,439
| +90% | +$13M |
|
1043
Rambus
RMBS
$9.74B
| $31M | 0.02% |
483,586
-305,890
| -39% | -$16.8M |
|
1044
Frontline
FRO
$9.67B
| $31M | 0.02% |
2,134,571
+482,199
| +29% | +$7.21M |
|
|
NXH
1045
Neighborhood Intelligence Inc
NXH
$378M
| $31M | 0.02% |
1,046,566
+965,987
| +1,199% | +$17.8M |
|
1046
Stryker
SYK
$127B
| $31M | 0.02% |
101,558
+39,789
| +64% | +$11.5M |
|
1047
PUT
Qorvo
QRVO
$8.19B
| $30.9M | 0.02% |
303,200
+41,900
| +16% | +$4.02M |
|
1048
Rivian
RIVN
$24.4B
| $30.9M | 0.02% |
1,853,628
+694,330
| +60% | +$9.7M |
|
1049
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $30.8M | 0.02% |
415,800
-918,300
| -69% | -$68.9M |
|
1050
Elastic
ESTC
$8.47B
| $30.6M | 0.02% |
477,282
+208,602
| +78% | +$13.1M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.